SUANFARMA - CORPORATE VIDEO

SUANFARMA was born in Spain in 1993 and is specialized in the development, production and commercialization of ingredients for the pharmaceutical, veterinary, and nutritional sectors.

During the last 5 years the company has achieved the highest growth in its history and has acquired 5 new companies in Spain, Portugal, Colombia and Italy, increasing significantly its industrial and development capacity. SUANFARMA Group is represented by over 650 people, with presence in over 70 countries.

At SUANFARMA, we are committed to health and innovation. We develop new technologies and processes to offer innovative products, following the trends of the world of health and the needs of our customers. We cover both “super sales” molecules and niche molecules or specialized therapies, controlling the production process from the intermediate to the final product.

Content provided by our supplier

SUANFARMA Group

ES
2015

On CPHI since
3

Certificates
500 - 999

Employees

Company types

CMO/CDMO

Distributor/Import Export

Manufacturer/Innovator

Primary activities

API Producer

Contract Manufacturer

Other Content from SUANFARMA Group (4)

Video Corporate video Cipan Lisbon

Founded in 1960, Cipan is a company committed to health, and this has been demonstrated in its more than 50-year history

Cipan has developed, either through its own investment or through CDO strategies, three generations of APIs derived from Tetracycline: Tetracycline, Minocycline, Lymecycline, Oxytetracycline, and other third-generation molecules that are currently in commercial phase (CMO) or development (CDO).
Video SUANNUTRA

SUANNUTRA is a reference company in the nutraceutical ingredients sector, supporting customers by satisfying their supply needs and accompanying them in their commercial success. We are present from research and development to market launch. We offer both essential ingredients and the most select compounds, with proven scientific evidence.
Video CIPAN

Founded in 1960, Cipan is a company committed to health, and this has been demonstrated in its more than 50-year history

Cipan has developed, either through its own investment or through CDO strategies, three generations of APIs derived from Tetracycline: Tetracycline, Minocycline, Lymecycline, Oxytetracycline, and other third-generation molecules that are currently in commercial phase (CMO) or development (CDO).
Video CIPAN

Founded in 1960, Cipan is a company committed to health, and this has been demonstrated in its more than 50-year history

Cipan has developed, either through its own investment or through CDO strategies, three generations of APIs derived from Tetracycline: Tetracycline, Minocycline, Lymecycline, Oxytetracycline, and other third-generation molecules that are currently in commercial phase (CMO) or development (CDO).